of marrow harvest and a staging marrow within three weeks 
prior to autologous transplantation. Pre-transplant 
specimens, and all subsequent specimens, will be reviewed 
by a Indiana University pathologist. 
10.0 RECORDS TO BE KEPT; 
The following forms will be maintained, sample forms can be 
found in Table 4. Data will be collected and reviewed by the 
principal investigator, Dr. Ken Cornetta. 
ECOG Leukemia On-Study (revised 1983) - within one month 
of entry 
IU Pathology and Cytogenetics Reports - Within one month 
of entry and within one month of each bone marrow 
aspiration or biopsy 
Bone Marrow Transplant Flow Sheets - Every three months 
for year one and then yearly until death 
Laboratory data will be reported on the LNL6/BMT Data 
Summary Form 
Interim Report Form - Every three months for year one and 
then yearly until death 
Summary and Evaluation - Within one month of the 100 day 
evaluation, at relapse or off study for other reason 
11.0 INFORMED CONSENT; 
The informed consent form for this protocol is supplied 
in Table 5. 
Patients entering this study will be patients who have 
agreed to undergo autologous bone marrow transplantation 
as treatment for their acute leukemia. The bone marrow 
transplant procedure and risks have been explained to the 
patient and have been agreed upon prior to being offered 
this protocol (either by consenting to protocol therapy 
or by consenting to standard bone marrow 
transplantation) . Therefore, the risks and procedures 
involved with bone marrow transplantation will not be 
included in the consent form for this study. 
Recombinant DNA Research, Volume 15 
[497] 
